Quick Heal Technologies Ltd

Quick Heal Tech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Quick Heal Technologies Ltd

₹ 180 -0.89%
05 Jun - close price
quickheal.com BSE: 539678 NSE: QUICKHEAL
About

Quick Heal Technologies is engaged in the business of providing security software products. The Company caters to both domestic and international market.

Key Points

Market Share
It is a leader in the cybersecurity enterprise solutions space in India, with over 30% market share. [1] In FY24, the company became the only Indian cybersecurity firm listed as a U.S. Artificial Intelligence Safety Institute Consortium Member. [2]

Website BSE NSE - BE
  • Market Cap ₹ 977 Cr.
  • Current Price ₹ 180
  • High / Low ₹ 417 / 125
  • Stock P/E
  • Book Value ₹ 80.5
  • Dividend Yield 0.00 %
  • ROCE -4.65 %
  • ROE -2.49 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -4.76% over past five years.
  • Company has a low return on equity of 1.11% over last 3 years.
  • Company has high debtors of 192 days.
  • Company's cost of borrowing seems high
  • Working capital days have increased from 188 days to 346 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Information Technology Information Technology IT - Software Software Products

Part of BSE Information Technology BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
49 51 78 82 80 70 73 71 65 57 84 72 49
65 67 67 70 70 68 70 74 74 67 74 71 78
Operating Profit -16 -15 11 12 10 3 3 -4 -8 -10 9 0 -29
OPM % -33% -29% 14% 14% 13% 4% 4% -5% -13% -17% 11% 1% -60%
10 5 6 4 7 5 5 5 6 6 4 9 4
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 4 3 3 3 3 3 3 3 4 3 3 4 4
Profit before tax -10 -13 13 13 14 5 5 -2 -7 -7 10 6 -30
Tax % -33% -4% 4% 20% -4% 16% 18% -105% -51% -21% 23% -15% -33%
-7 -13 13 10 14 4 4 0 -3 -6 8 7 -20
EPS in Rs -1.25 -2.40 2.43 1.89 2.62 0.75 0.77 0.02 -0.60 -1.02 1.46 1.22 -3.68
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
286 302 300 318 315 286 333 342 278 292 280 261
194 200 210 198 187 195 192 235 276 274 286 290
Operating Profit 92 102 90 120 128 92 141 107 2 18 -7 -29
OPM % 32% 34% 30% 38% 41% 32% 42% 31% 1% 6% -2% -11%
8 10 25 30 33 31 24 19 22 21 21 23
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 20 24 31 27 24 22 19 17 16 13 13 14
Profit before tax 80 88 84 123 137 101 146 109 8 26 1 -21
Tax % 33% 34% 37% 33% 33% 27% 27% 23% 20% 8% -404% -47%
54 58 53 83 92 74 107 83 6 24 5 -11
EPS in Rs 8.81 8.27 7.59 11.79 13.01 11.59 16.66 14.34 1.21 4.53 0.93 -2.01
Dividend Payout % 85% 30% 33% 25% 15% 35% 24% 31% 207% 66% 0% 0%
Compounded Sales Growth
10 Years: -1%
5 Years: -5%
3 Years: -2%
TTM: -7%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -497%
Stock Price CAGR
10 Years: -3%
5 Years: -5%
3 Years: 4%
1 Year: -51%
Return on Equity
10 Years: 8%
5 Years: 4%
3 Years: 1%
Last Year: -2%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 61 70 70 70 71 64 64 58 53 54 54 54
Reserves 270 559 592 653 719 580 687 570 367 383 387 382
0 0 0 0 0 0 0 0 0 0 0 0
97 88 72 57 63 52 75 88 74 76 83 110
Total Liabilities 428 717 734 781 853 697 827 716 493 513 525 547
111 142 185 173 165 158 146 137 124 117 119 122
CWIP 74 55 14 14 11 3 2 0 0 3 0 0
Investments 130 115 182 306 390 310 416 318 198 190 179 213
113 405 353 287 288 225 263 261 171 203 226 212
Total Assets 428 717 734 781 853 697 827 716 493 513 525 547

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
77 78 36 94 61 71 99 80 31 18 -22 15
-53 -163 -73 -122 -37 148 -92 126 185 6 16 -26
-18 189 -20 -19 -24 -221 0 -214 -212 2 -10 3
Net Cash Flow 7 104 -57 -47 1 -3 6 -9 4 26 -17 -8
Free Cash Flow 11 42 2 80 54 60 90 79 32 12 -36 6
CFO/OP 116% 92% 73% 100% 91% 114% 90% 106% 2,064% 102% 325% -80%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 83 112 118 118 145 144 165 184 161 165 218 192
Inventory Days 181 144
Days Payable 864 1,103
Cash Conversion Cycle -600 -847 118 118 145 144 165 184 161 165 218 192
Working Capital Days -23 29 49 70 92 94 98 102 83 88 130 346
ROCE % 24% 18% 14% 18% 18% 14% 21% 15% 0% 6% -0% -5%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Employee Headcount
Number

Log in to view insights

Please log in to see hidden values.

Login
Enterprise vs Consumer Revenue Mix (Enterprise %)
%
R&D Spend as % of Net Revenue
%
Active Device Endpoints / Active Licenses
Million
Channel Partners / Retail Network
Number
Distributors
Number
Number of Patents Held
Number
Total Enterprise Customers
Number
Retail/Consumer Market Share in India
%
R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

63 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
73.08% 73.06% 72.76% 72.48% 72.44% 72.08% 71.92% 71.82% 71.79% 71.63% 71.54% 71.50%
2.02% 1.56% 1.66% 1.65% 1.54% 1.61% 1.81% 2.03% 1.16% 0.50% 0.45% 0.73%
0.00% 1.13% 1.44% 2.06% 2.41% 2.62% 2.84% 2.63% 2.58% 2.33% 2.29% 1.16%
24.91% 24.23% 24.13% 23.81% 23.61% 23.68% 23.42% 23.52% 24.46% 25.53% 25.73% 26.62%
No. of Shareholders 63,44557,52850,24946,92346,79947,78147,72049,83753,85655,91056,03056,399

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls